Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Onconic Therapeutics, Inc. (476060) Stock Price & Analysis

476060 Stock Chart & Stats

₩12,570.00₩270.00(2.20%)
At close: 3:30 PM GMT+9
₩12.5K₩15K₩17.5KAug 18Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
KRW 12,370.00 - KRW 13,270.00
52-Week Range
KRW 8,790.00 - KRW 28,900.00
Previous Close
KRW 12,300.00
Volume
N/A
Average Volume (3M)
132.95K
Market Cap
KRW 570.78B
Enterprise Value
KRW 554.24B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
23.1
Beta
0.33
Next Earnings
Nov 17, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Onconic Therapeutics, Inc. News

476060 FAQ

What was Onconic Therapeutics, Inc.’s price range in the past 12 months?
Onconic Therapeutics, Inc. lowest stock price was ₩8790.00 and its highest was ₩28900.00 in the past 12 months.
What is Onconic Therapeutics, Inc.’s market cap?
Onconic Therapeutics, Inc.’s market cap is ₩570.78B.
When is Onconic Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Onconic Therapeutics, Inc.’s earnings last quarter?
Onconic Therapeutics, Inc. released its earnings results on Aug 12, 2026. The company reported ₩83.117 earnings per share for the quarter.
Is Onconic Therapeutics, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Onconic Therapeutics, Inc. pay dividends?
Onconic Therapeutics, Inc. does not currently pay dividends.
What is Onconic Therapeutics, Inc.’s EPS estimate?
Onconic Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onconic Therapeutics, Inc. have?
Onconic Therapeutics, Inc. has 45,407,840 shares outstanding.
What happened to Onconic Therapeutics, Inc.’s price movement after its last earnings report?
Onconic Therapeutics, Inc. reported an EPS of ₩83.117 in its last earnings report. Following the earnings report the stock price went up 6.397%.
Which hedge fund is a major shareholder of Onconic Therapeutics, Inc.?
Currently, no hedge funds are holding shares in KR:476060
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology